Rational design, integrated in silico and biochemical evaluation of the ErA–ARG1 chimeric enzyme

Key Points

• This research aims to develop and evaluate a new chimeric enzyme, ErA–ARG1, for potential immunobiological applications.
• Rational design of the ErA–ARG1 chimeric enzyme.
• Integrated in silico modeling and biochemical evaluation to assess functionality.
• Submissions for presentation at the International Symposium on Immunobiologicals.
• Successful design of the ErA–ARG1 chimeric enzyme with anticipated functional properties.
• Presentation accepted at a prominent immunobiological symposium.